DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders.
52W Range
24thpctl
Volume
0.64×avg
Market Cap
344.31MUSD
P/E Ratio
-8.9TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
DiaMedica Therapeutics Inc.
DMACNASDAQ Capital Market·USD·Closed
DiaMedica Therapeutics Inc.
DMACNASDAQ·USD·Closed
$6.39
−5.33%
$6.39
−$0.36 (5.33%)
52W Range
24thpctl
Volume
0.64×avg
Mkt Cap
344.31MUSD
P/E
-8.9TTM
Div Yield
–ann
DMAC: DiaMedica Therapeutics Inc. Stock Analysis | finqOS
